The Food and Drug Administration (FDA) has cleared a new blood test designed to help diagnose Alzheimer’s disease, which is expected to be available later this year. The blood test, known as ...
Outside advisers to the Food and Drug Administration on Monday voted unanimously that the benefits of Eli Lilly's experimental Alzheimer's treatment donanemab outweighed its risks, and agreed that ...
On August 24, 2026, the U.S. Food & Drug Administration (FDA) cleared the use of a new single-biomarker blood test to help doctors look for signs of Alzheimer’s disease in older adults 55 and older ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
On August 24, 2026, the U.S. FDA cleared a new single-biomarker blood test to help doctors detect signs of Alzheimer’s disease. The test helps doctors determine both rule-in (positive result) and rule ...